nvidia has introduced tools aimed at utilizing ai agents to assist in drug discovery. The company's new biomeno agent toolkit is part of this effort, with some reports indicating it is being adopted by life sciences leaders to accelerate ai-driven drug discovery. Other companies, including amazon web services and tecan, are also developing or integrating ai capabilities for similar purposes.